Skip to content

Administration of absorbable hemostatic reduces postoperative blood loss in calcaneal fractures: a randomized controlled trial

Administration of absorbable hemostatic reduces postoperative blood loss in calcaneal fractures: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032567
Enrollment
Unknown
Registered
2020-05-02
Start date
2020-05-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcaneal fracture

Interventions

Group A:Absorbable hemostatic

Sponsors

Honghui Hospital, Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. It was diagnosed as calcaneal fracture after imaging examination and special physical examination; 2. After CT scanning, it was classified as type III - IV according to Sanders; 3. The age at the time of injury was >= 18 years old; 4. The operative approach was L-shaped incision with lateral extension of calcaneus; 5. Voluntarily participated in the clinical trial and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Open calcaneal fracture, pathological calcaneal fracture and old calcaneal fracture; 2. Bilateral calcaneal fracture; 3. Incomplete skin or infection and ulcer in operation area; 4. Smoking and diabetes; 5. Lower extremity dysfunction caused by fracture, deformity, joint degeneration or other diseases in other parts.

Design outcomes

Primary

MeasureTime frame
Hgb;postoperative drainage;Incidence of wound complications;operation duration;wound healing duration;swelling degree of lateral calcaneal flap;

Countries

China

Contacts

Public ContactLu Jun

Honghui Hospital, Xi'an Jiaotong University

lujun23@126.com+86 13991953203

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026